New research has thrown into question the current method of treating Crohn’s disease — opening the door to a safer and more effective treatment option for sufferers of the chronic disease. The new approach, called “top-down” therapy, employs early use of immune-suppressing drugs combined with an antibody in order to address the disease from the start. Symptom-treating steroids may never even be needed.